Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000082520 | SCV000114562 | benign | not specified | 2012-07-17 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000082520 | SCV000315762 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Illumina Laboratory Services, |
RCV000281642 | SCV000464025 | benign | Autosomal recessive polycystic kidney disease | 2018-01-13 | criteria provided, single submitter | clinical testing | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. |
Invitae | RCV000281642 | SCV000557650 | benign | Autosomal recessive polycystic kidney disease | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Gene |
RCV001705788 | SCV001890306 | benign | not provided | 2018-07-14 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001292049 | SCV001480691 | likely benign | Polycystic kidney disease | no assertion criteria provided | clinical testing | The PKHD1 p.Val3837Ile variant was not identified in the literature nor was it identified in the GeneInsight-COGR, LOVD 3.0, databases. The variant was identified in dbSNP (ID: rs9474034) as With other allele, ClinVar (classified as benign by Initae, EGL Diagnistics; classified as likely benign by illumina), Clinvitae, RWTH AAachen University ARPKD database, databases. The variant was identified in control databases in 4161 of 276500 chromosomes (281 homozygous) at a frequency of 0.02 increasing the likelihood this could be a low frequency benign variant (Genome Aggregation Database Feb 27, 2017). Breakdown of the observations by population include African in 3772 of 24000 chromosomes (freq: 0.2), Other in 47 of 6438 chromosomes (freq: 0.01), Latino in 264 of 34314 chromosomes (freq: 0.01), EuropeanNon-Finnish in 64 of 126248 chromosomes (freq: 0.001), and SouthAsian in 14 of 30766 chromosomes (freq: 0.001), while the variant was not observed in the Ashkenazi Jewish, East Asian, European Finnish, populations. The p.Val3837= residue is not conserved in mammals and computational analyses (PolyPhen-2, SIFT, AlignGVGD, BLOSUM, MutationTaster) do not suggest a high likelihood of impact to the protein; however, this information is not predictive enough to rule out pathogenicity. The p.Val3837Ile variant occurs in the last three bases of the exon. This position has been shown to be part of the splicing consensus sequence and variants involving this position sometimes affect splicing. In addition, 2 of 5 in silico or computational prediction software programs (SpliceSiteFinder, MaxEntScan, NNSPLICE, GeneSplicer, HumanSpliceFinder) predict a greater than 10% difference in splicing. In summary, based on the above information, the clinical significance of this variant cannot be determined with certainty at this time although we would lean towards a more benign role for this variant. This variant is classified as likely benign. | |
Natera, |
RCV000281642 | SCV002075477 | benign | Autosomal recessive polycystic kidney disease | 2017-05-11 | no assertion criteria provided | clinical testing |